AU2003274900A8 - Cellular reprogramming in peptide hydrogel and uses thereof - Google Patents

Cellular reprogramming in peptide hydrogel and uses thereof

Info

Publication number
AU2003274900A8
AU2003274900A8 AU2003274900A AU2003274900A AU2003274900A8 AU 2003274900 A8 AU2003274900 A8 AU 2003274900A8 AU 2003274900 A AU2003274900 A AU 2003274900A AU 2003274900 A AU2003274900 A AU 2003274900A AU 2003274900 A8 AU2003274900 A8 AU 2003274900A8
Authority
AU
Australia
Prior art keywords
peptide hydrogel
cellular reprogramming
reprogramming
cellular
hydrogel
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003274900A
Other versions
AU2003274900A1 (en
Inventor
Carlos Semino
James Sherley
Shuguang Zhang
Collette Shen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Massachusetts Institute of Technology
Original Assignee
Massachusetts Institute of Technology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Massachusetts Institute of Technology filed Critical Massachusetts Institute of Technology
Publication of AU2003274900A1 publication Critical patent/AU2003274900A1/en
Publication of AU2003274900A8 publication Critical patent/AU2003274900A8/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/067—Hepatocytes
    • C12N5/0671—Three-dimensional culture, tissue culture or organ culture; Encapsulated cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0676—Pancreatic cells
    • C12N5/0677—Three-dimensional culture, tissue culture or organ culture; Encapsulated cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K2035/126—Immunoprotecting barriers, e.g. jackets, diffusion chambers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/01—Modulators of cAMP or cGMP, e.g. non-hydrolysable analogs, phosphodiesterase inhibitors, cholera toxin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/06—Anti-neoplasic drugs, anti-retroviral drugs, e.g. azacytidine, cyclophosphamide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/11—Epidermal growth factor [EGF]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/115—Basic fibroblast growth factor (bFGF, FGF-2)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/998—Proteins not provided for elsewhere
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
    • C12N2506/14—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from hepatocytes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00—Supports or coatings for cell culture, characterised by material
    • C12N2533/50—Proteins

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AU2003274900A 2002-07-15 2003-07-15 Cellular reprogramming in peptide hydrogel and uses thereof Abandoned AU2003274900A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US19394202A 2002-07-15 2002-07-15
US10/193,942 2002-07-15
PCT/US2003/021981 WO2004007683A2 (en) 2002-07-15 2003-07-15 Cellular reprogramming in peptide hydrogel and uses thereof

Publications (2)

Publication Number Publication Date
AU2003274900A1 AU2003274900A1 (en) 2004-02-02
AU2003274900A8 true AU2003274900A8 (en) 2004-02-02

Family

ID=30114638

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003274900A Abandoned AU2003274900A1 (en) 2002-07-15 2003-07-15 Cellular reprogramming in peptide hydrogel and uses thereof

Country Status (2)

Country Link
AU (1) AU2003274900A1 (en)
WO (1) WO2004007683A2 (en)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2457296A1 (en) 2003-08-19 2005-02-19 Takahiro Ochiya Methods for inducing differentiation of pluripotent cells
JP4404030B2 (en) 2004-10-07 2010-01-27 トヨタ自動車株式会社 Control device and control method for internal combustion engine
AU2005323062A1 (en) * 2005-01-04 2006-07-13 The Brigham And Women's Hospital, Inc. Sustained delivery of PDGF using self-assembling peptide nanofibers
US8299032B2 (en) 2005-06-27 2012-10-30 Menicon Co., Ltd. Self-assembling peptide and gel produced from the same
US8647867B2 (en) 2005-09-30 2014-02-11 National University Corportion Okayama University Cell cultivation method and cell culture
JP2007217375A (en) * 2006-02-17 2007-08-30 Nagoya Institute Of Technology Self-assembly peptide
JP2007217376A (en) * 2006-02-17 2007-08-30 Nagoya Institute Of Technology Self-assembly peptide composition
WO2008024409A1 (en) * 2006-08-22 2008-02-28 The Trustees Of Columbia University In The City Of New York Progenitor cell replication and differentiation in 3d
US8080418B2 (en) 2007-03-09 2011-12-20 Corning Incorporated Method of making a three dimensional cell culture matrix
US9084752B2 (en) * 2009-12-14 2015-07-21 The University Of Hong Kong Compositions and methods for controlling proliferation and differentiation of cells
FI123988B (en) 2010-10-27 2014-01-31 Upm Kymmene Corp Cell Culture Materials
US8546338B2 (en) 2010-12-08 2013-10-01 Johnson & Johnson Consumer Companies, Inc. Self-assembling hydrogels based on dicephalic peptide amphiphiles
FI125965B (en) 2012-09-25 2016-04-29 Upm Kymmene Corp Three-dimensional cell culture
FI126398B (en) 2014-12-18 2016-11-15 Upm Kymmene Corp Method for chemical testing
DE102015000363A1 (en) 2015-01-20 2016-07-21 Emc Microcollections Gmbh New modular functionalizable peptide hydrogels
EP3418377B1 (en) 2017-06-22 2024-04-17 UPM-Kymmene Corporation Supportive nanofibrillar cellulose scaffold for expanding cells
CN109810943A (en) * 2019-03-21 2019-05-28 河南科技大学 One boar muscle-derived mescenchymal stem cell isolation medium and isolated culture method
JP2023516484A (en) 2020-03-11 2023-04-19 ビット バイオ リミテッド Hepatocyte production method
US20230392123A1 (en) 2020-10-15 2023-12-07 Katholieke Universiteit Leuven Spheroidal self-assembled peptide hydrogels comprising cells

Also Published As

Publication number Publication date
AU2003274900A1 (en) 2004-02-02
WO2004007683A2 (en) 2004-01-22
WO2004007683A3 (en) 2005-09-09

Similar Documents

Publication Publication Date Title
AU2003274900A8 (en) Cellular reprogramming in peptide hydrogel and uses thereof
IL165909A0 (en) Devices and methodologies useful in body aesthetics
AU2003238714A8 (en) Export and modification of (poly)peptides in the lantibiotic way
PT2702871T (en) Collagen biofabric and use thereof
EP1652855A4 (en) Polypeptides having brain -localizing activity and uses thereof
EP1565205A4 (en) Interferon-alpha polypeptides and conjugates
EP1687330A4 (en) Peptides with anti-obesity activity and other related uses
EP1476176A4 (en) Transport peptides and uses therefor
AU2003272423A8 (en) Centrosome proteins and uses thereof
EP1565553A4 (en) Recombinant catalytic polypeptides and their uses
GB0309064D0 (en) Modified peptides and their uses
AU2003290886A8 (en) Modified alpha-msh peptides and derivatives thereof
HK1209049A1 (en) Survivin-derived peptides and use thereof
AU2003290222A1 (en) Hypercoiling polymers and their use in cellular delivery
AU2002247088A1 (en) Cellular reprogramming in peptide hydrogel and uses thereof
EP1541677A4 (en) Novel proteins and use thereof
EP1577322A4 (en) Novel proteins and use thereof
IL150087A0 (en) Dermaseptin-derived peptides and their use in delivery systems
EP1699809A4 (en) Amniotic-derived peptide and uses thereof
GB0223860D0 (en) Polypeptide methods and means
IL166102A0 (en) Beta-sheet breaking peptides and their use
AU2002951912A0 (en) Tryptase polypeptide and uses thereof
GB0226441D0 (en) Growth hormone variation in humans and their uses
AU2003303464A8 (en) Centrosome-associated protein and applications thereof
AU2003263751A8 (en) Novel proteins and their uses

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase